Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients

To date, only few data concerning the biologically active, free form of testosterone (FT) are available in metastatic prostate cancer (mPC) and the impact of FT on disease, therapy and outcome is largely unknown. We retrospectively studied the effect of docetaxel on FT and total testosterone (TT) se...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappler, Paula, Morgan, Michael A., Ivanyi, Philipp, Brunotte, Stefan J., Ganser, Arnold, Reuter, Christoph W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361102/
https://www.ncbi.nlm.nih.gov/pubmed/34385568
http://dx.doi.org/10.1038/s41598-021-95874-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361102/
https://www.ncbi.nlm.nih.gov/pubmed/34385568
http://dx.doi.org/10.1038/s41598-021-95874-y

Ejemplares similares